Acral Melanoma: Clinical Advances and Hope for the Future

被引:0
作者
Perez, Matthew C. [1 ]
Messina, Jane L. [1 ,2 ]
Karapetyan, Lilit [1 ]
Neves, Rogerio I. [1 ,3 ]
Sondak, Vernon K. [1 ,4 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Program Plast Surg & Reconstruct Oncol, Tampa, FL USA
[4] Dept Cutaneous Oncol, 10920 N McKinley Dr, Tampa, FL 33612 USA
关键词
Acral lentiginous melanoma; acral melanoma; cutaneous melanoma; LENTIGINOUS MELANOMA; CUTANEOUS MELANOMA; METASTATIC MELANOMA; MALIGNANT-MELANOMA; EXCISION MARGINS; SURGICAL MARGINS; BRAF INHIBITORS; CTLA-4; BLOCKADE; UNITED-STATES; SINGLE-ARM;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acral melanoma is a rare subtype of melanoma with unique histologic and biologic characteristics. Given its relative rarity compared with nonacral cutaneous melanoma, acral melanoma has been understudied and underrepresented in modern-day prospective clinical trials that have shaped the contemporary management of advanced cutaneous melanoma. Therefore, treatment principles for advanced acral melanoma are mostly derived from retrospective anal-yses or extrapolated from data largely based on nonacral cutaneous melanoma. Further studies are warranted to evaluate the efficacy of systemic immune and targeted molecular therapies, and to identify molecular targets for patients with advanced acral melanoma.
引用
收藏
页码:400 / 409
页数:10
相关论文
共 88 条
[11]   Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma [J].
Bhave, Prachi ;
Ahmed, Tasnia ;
Lo, Serigne N. ;
Shoushtari, Alexander ;
Zaremba, Anne ;
Versluis, Judith M. ;
Mangana, Joanna ;
Weichenthal, Michael ;
Si, Lu ;
Lesimple, Thierry ;
Robert, Caroline ;
Trojanello, Claudia ;
Wicky, Alexandre ;
Heywood, Richard ;
Tran, Lena ;
Batty, Kathleen ;
Dimitriou, Florentia ;
Stansfeld, Anna ;
Allayous, Clara ;
Schwarze, Julia K. ;
Mooradian, Meghan J. ;
Klein, Oliver ;
Mehmi, Inderjit ;
Roberts-Thomson, Rachel ;
Maurichi, Andrea ;
Yeoh, Hui-Ling ;
Khattak, Adnan ;
Zimmer, Lisa ;
Blank, Christian U. ;
Ramelyte, Egle ;
Kaehler, Katharina C. ;
Roy, Severine ;
Ascierto, Paolo A. ;
Michielin, Olivier ;
Lorigan, Paul C. ;
Johnson, Douglas B. ;
Plummer, Ruth ;
Lebbe, Celeste ;
Neyns, Bart ;
Sullivan, Ryan ;
Hamid, Omid ;
Santinami, Mario ;
McArthur, Grant A. ;
Haydon, Andrew M. ;
Long, Georgina, V ;
Menzies, Alexander M. ;
Carlino, Matteo S. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (07)
[12]   Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015 [J].
Bian, Shelly X. ;
Hwang, Lindsay ;
Hwang, Jennifer ;
Ragab, Omar ;
In, Gino K. ;
Peng, David ;
Lin, Eugene .
PIGMENT CELL & MELANOMA RESEARCH, 2021, 34 (06) :1049-1061
[13]  
Bradford PT, 2009, ARCH DERMATOL, V145, P427, DOI 10.1001/archdermatol.2008.609
[14]   Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America [J].
Castaneda, C. A. ;
Torres-Cabala, C. ;
Castillo, M. ;
Villegas, V. ;
Casavilca, S. ;
Cano, L. ;
Sanchez, J. ;
Dunstan, J. ;
Calderon, G. ;
De la Cruz, M. ;
Cotrina, J. M. ;
Gomez, H. L. ;
Galvez, R. ;
Abugattas, J. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (12) :1478-1488
[15]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[16]   Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma [J].
Cheraghlou, Shayan ;
Ugwu, Nelson ;
Girardi, Michael .
JAMA DERMATOLOGY, 2022, 158 (01) :51-58
[17]   Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma [J].
Chesney, Jason ;
Puzanov, Igor ;
Collichio, Frances ;
Singh, Parminder ;
Milhem, Mohammed M. ;
Glaspy, John ;
Hamid, Omid ;
Ross, Merrick ;
Friedlander, Philip ;
Garbe, Claus ;
Logan, Theodore F. ;
Hauschild, Axel ;
Lebbe, Celeste ;
Chen, Lisa ;
Kim, Jenny J. ;
Gansert, Jennifer ;
Andtbacka, Robert H. I. ;
Kaufman, Howard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) :1658-+
[18]   Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma [J].
Chesney, Jason A. ;
Ribas, Antoni ;
Long, Georgina, V ;
Kirkwood, John M. ;
Dummer, Reinhard ;
Puzanov, Igor ;
Hoeller, Christoph ;
Gajewski, Thomas F. ;
Gutzmer, Ralf ;
Rutkowski, Piotr ;
Demidov, Lev ;
Arenberger, Petr ;
Shin, Sang Joon ;
Ferrucci, Pier Francesco ;
Haydon, Andrew ;
Hyngstrom, John ;
van Thienen, Johannes, V ;
Haferkamp, Sebastian ;
Guilera, Josep Malvehy ;
Rapoport, Bernardo Leon ;
VanderWalde, Ari ;
Diede, Scott J. ;
Anderson, James R. ;
Treichel, Sheryl ;
Chan, Edward L. ;
Bhatta, Sumita ;
Gansert, Jennifer ;
Hodi, Frank Stephen ;
Gogas, Helen .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) :528-+
[19]   Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases [J].
Chi, Zhihong ;
Li, Siming ;
Sheng, Xinan ;
Si, Lu ;
Cui, Chuanliang ;
Han, Mei ;
Guo, Jun .
BMC CANCER, 2011, 11
[20]  
Cohn-Cedermark G, 2000, CANCER-AM CANCER SOC, V89, P1495, DOI 10.1002/1097-0142(20001001)89:7<1495::AID-CNCR12>3.0.CO